0.269
VolitionRX Ltd Aktie (VNRX) Neueste Nachrichten
VolitionRx to eliminate veterinary CEO role as part of cost-realignment - Investing.com Australia
VolitionRx announces new paper on Capture-Seq, achieves 180-fold enrichment - TipRanks
VolitionRx (VNRX) Unveils Innovative Cancer Detection Method - GuruFocus
Volition (NYSE AMERICAN: VNRX) posts 100% sensitivity in 70-person liquid biopsy study - Stock Titan
VolitionRx’s (VNRX) “Buy” Rating Reaffirmed at D. Boral Capital - Defense World
VolitionRx downgraded to Hold from Buy at Maxim - MSN
Why VolitionRX Limited stock is a strong buy call2025 Pullback Review & Risk Controlled Daily Plans - Newser
VolitionRx’s Sepsis Biomarker Selected for French National Healthcare Initiative - citybuzz
VolitionRX (VNRX): Analyst Maintains 'Buy' Rating Amidst Stable Price Target | VNRX Stock News - GuruFocus
VolitionRx Limited Announces Inclusion of its Nu.Q® NETs Assay as Innovative Biomarker in France's Real-World Evaluation of Early Detection of Sepsis - Yahoo Finance
How VolitionRx Limited stock valuations compare to rivalsGap Up & Fast Entry Momentum Trade Alerts - Newser
VolitionRx (NYSE:VNRX) Lowered to “Hold” Rating by Maxim Group - Defense World
How VolitionRx Limited stock reacts to job market data2025 Market Sentiment & Consistent Growth Equity Picks - Newser
VNRX: Maxim Group Downgrades VolitionRX to Hold | VNRX Stock New - GuruFocus
Healthy Upside Potential: VolitionRX Ltd (VNRX) - Setenews
VolitionRx (VNRX) Insider Trading Activity 2025 - MarketBeat
VolitionRX (VNRX) Analyst Rating Update: Maintain 'Buy' with $5 Target | VNRX Stock News - GuruFocus
VolitionRX Ltd (VNRX) is looking forward to a strong quarter - Setenews
VolitionRx (VNRX) Stock Surges with First Sale of Nu.Q Cancer Assays to European Cancer Center - parameter.io
VolitionRx announces first sale of Nu.Q Cancer assays to French hospital - Investing.com India
VolitionRx announces first sale of Nu.Q Cancer assays to French hospital By Investing.com - Investing.com South Africa
Nu.Q Cancer Assays Sold for Certification at Lyon Center, VolitionRx (NYSE: VNRX) - Stock Titan
Freedom Capital Markets lowers VolitionRX stock price target on delayed revenue growth - Investing.com Australia
Freedom Capital Markets lowers VolitionRX stock price target on delayed revenue growth By Investing.com - Investing.com South Africa
Can VolitionRX Limited stock sustain breakout momentumEarnings Risk Report & Stepwise Trade Execution Plans - newser.com
Will VolitionRX Limited stock beat international competitionQuarterly Earnings Summary & Capital Efficient Trading Techniques - newser.com
What makes VolitionRx Limited stock attractive to growth fundsJuly 2025 Retail & Accurate Trade Setup Notifications - newser.com
Smart tools for monitoring VolitionRx Limited’s price actionWeekly Market Summary & Reliable Breakout Stock Forecasts - newser.com
How strong is VolitionRx Limited stock balance sheet2025 Major Catalysts & Safe Capital Growth Plans - newser.com
How VolitionRX Limited stock trades after rate cutsQuarterly Performance Summary & Expert-Curated Trade Recommendations - newser.com
H.C. Wainwright lowers VolitionRX stock price target on valuation update By Investing.com - Investing.com Nigeria
Are Smart Investors Making the Right Decision? VolitionRX Ltd (VNRX) - Setenews
H.C. Wainwright lowers VolitionRX stock price target on valuation update - Investing.com
VolitionRx price target lowered to $1.50 from $2.50 at H.C. Wainwright - MSN
Reynolds, Volitionrx CEO, buys $7,000 in VNRX stock By Investing.com - Investing.com Nigeria
Reynolds, Volitionrx CEO, buys $7,000 in VNRX stock - Investing.com
CEO Reynolds Buys 20,000 ($7K) Of VolitionRX Ltd [VNRX] - TradingView
[Form 4] VOLITIONRX LTD Insider Trading Activity - Stock Titan
VolitionRX (VNRX) Target Price Lowered by HC Wainwright & Co. | - GuruFocus
VolitionRX (VNRX): Analyst Jason Kolbert Reaffirms Buy Rating wi - GuruFocus
VolitionRx Limited Reports Q3 2025 Financial Growth - MSN
VolitionRx Ltd. Earnings Call Highlights Growth and Partnerships - The Globe and Mail
Using Ichimoku Cloud for VolitionRx Limited technicalsLong Setup & Detailed Earnings Play Alerts - newser.com
Is VolitionRX Limited stock resilient in recession scenariosSell Signal & High Return Trade Opportunity Guides - newser.com
VolitionRx Limited (AMEX:VNRX) Q3 2025 Earnings Call Transcript - Insider Monkey
Volitionrx Ltd earnings missed by $0.01, revenue fell short of estimates - Investing.com Nigeria
Market reaction to VolitionRx Limited’s recent newsTrade Signal Summary & Technical Pattern Based Signals - newser.com
Earnings call transcript: VolitionRx Ltd reports Q3 2025 revenue growth, stock stable - Investing.com Nigeria
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):